Zdrowie i gospodarka · 19/11/2004

FDA Extends Deadline for Continuous Marketing Applications Pilot 2 Program

The Food and Drug Administration (FDA) is extending the deadline for applications to its Continuous Marketing Applications (CMA) Pilot 2 program, which aims to improve the development of fast-track prescription drugs, to accommodate applications from the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) review divisions that have not yet submitted acceptable applications.